General Information of the Compound
| Compound ID |
CP0521941
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
4-[((8S)-8-{[(2R)-2-(3-Chlorophenyl)-2-hydroxyethyl]amino}-6,7,8,9-tetrahydro-5H-benzo[a]cyclohepten-2-yl)oxy]benzoic Acid
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C26H26ClNO4
|
||||||||||||||||||
| Molecular Weight |
451.95
|
||||||||||||||||||
| Canonical SMILES |
O[C@@H](CN[C@H]1CCCc2ccc(Oc3ccc(cc3)C(O)=O)cc2C1)c1cccc(Cl)c1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C26H26ClNO4/c27-21-5-1-4-19(13-21)25(29)16-28-22-6-2-3-17-7-12-24(15-20(17)14-22)32-23-10-8-18(9-11-23)26(30)31/h1,4-5,7-13,15,22,25,28-29H,2-3,6,14,16H2,(H,30,31)/t22-,25-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
DYVUJRZDLWHSRJ-DHLKQENFSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01179, Beta-1 adrenergic receptor
Protein ID: PT01493, Beta-3 adrenergic receptor